Welcome to the DJO Global, Inc. Investor Center. Whether you are an analyst or journalist, you have come to the right place for information on DJO. Here you will find facts about our Company, governance, press releases, financial results, annual reports and other useful information. On November 20, 2007, DJO consummated its merger with ReAble Therapeutics, Inc. As a result of the merger, DJO's common stock ceased trading on the NYSE at the close of the market on November 20, 2007.

The following DJO Global, Inc. press releases contain information believed to be accurate when produced and posted but that may have been superseded by subsequent events and the passage of time. DJO Global, Inc. makes its press releases from the past year available for viewing, but the Company cautions that these press releases are not reviewed or updated, and disclaims any intent or undertaking to do so. By viewing these archived materials, you acknowledge that you understand this cautionary statement.

Recent Press Releases

SAN DIEGO, CA, July 28, 2015DJO Global, Inc. (“DJO” or the “Company”), a leading global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results for its public reporting subsidiary, DJO Finance LLC (“DJOFL”), for the second quarter ended June 27,... Read more

DJO Global, Inc. is publishing this notice, pursuant to the requirements of Treas. Reg. §1.1273-2(f) (the “Regulation”), with respect to the exchange offer (the “Exchange Offer”) by its indirect subsidiaries, DJO Finance LLC (“DJO LLC”) and DJO Finance Corporation (together with DJO LLC, the “Issuers”), which was completed on May... Read more

SAN DIEGO, CA, July 14, 2015 – DJO Global, Inc. (“DJO” or the “Company”), a leading global provider of sports medicine technology products designed to get and keep athletes moving, announced today the FDA clearance and launch of Compex Wireless USA, a wireless electric muscle stimulation device.

As a... Read more